Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chenodeoxycholic acid route offers high purity lithocholic acid. Safe reagents and scalable process reduce manufacturing costs for pharmaceutical supply chains.
Advanced P450 enzyme mutant technology enables efficient ursodeoxycholic acid production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN112341516A reveals a high-selectivity vanadyl-catalyzed epoxidation route for Obeticholic Acid intermediates, offering significant cost reduction and supply chain reliability.
Patent CN114539342B reveals an industrial method for TUDCA using alcohol solvents to reduce impurities, offering cost-effective pharma intermediate manufacturing.
Novel esterification-crystallization method removes double oxide impurities, ensuring superior quality for ursodeoxycholic acid production.
Patent CN115626944A details a novel oxidation route for Cholic Acid Intermediate A5, offering cost-effective plant-based synthesis alternatives to animal extraction.
Patent CN113024624A details a novel 8-step synthesis of deoxycholic acid from cholic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Novel recrystallization patent enhances Obeticholic Acid purity supply chain stability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN106977572A reveals a novel two-step synthesis route for lithocholic acid offering high purity and significant supply chain cost reduction advantages.
Patent CN105732758B details novel cholic acid derivatives with high antitumor activity. This report analyzes scalable synthesis methods offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Patent CN107298694A reveals a novel Obeticholic Acid synthesis route using cholic acid. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel process for Aramchol using cholic acid. High optical purity, reduced steps. Ideal for API manufacturing cost reduction and supply chain stability.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Patent CN119506235A reveals directed evolution for UDCA. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN112588319A reveals a novel silane-catalyzed route for TUDCA synthesis, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel chiral catalyst hydrogenation method for ursodesoxycholic acid ensures high yield and purity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102070693A details a high-yield chiral hydrogenation method for ursodeoxycholic acid, offering superior purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN107099516B reveals a stable 7β-hydroxysteroid dehydrogenase mutant enabling high-concentration ursodeoxycholic acid synthesis with superior thermal stability and simplified downstream processing.
Patent CN118745205A details a plant-derived ursodeoxycholic acid synthesis avoiding animal risks. Offers high purity and scalable supply chain solutions.
Patent CN118638174A reveals a plant-based UDCA synthesis route. Achieve 99.91% purity with reduced viral risk and scalable enzymatic steps for reliable supply.